Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
RegenxBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RegenxBio Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
REGENXBIO Raises USD70.5 Million in Series D Financing 13
REGENXBIO Raises USD30 Million in Series C Financing 16
REGENXBIO Raises USD7.9 Million in Venture Financing 18
ReGenX Biosciences Raises US$7.9 Million In Venture Financing 19
Partnerships 20
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 20
Silverstein Foundation, RegenxBio and OrbiMed Advisors Form Joint Venture 21
ABL Enters into Contract Manufacturing Agreement with RegenxBio 22
Fidelity Biosciences Forms Joint Venture With ReGenX Biosciences 23
Licensing Agreements 24
Abeona Therapeutics Enters into Licensing Agreement with RegenxBio 24
Ultragenyx Pharma Exercises Option for Licensing Agreement with Regenxbio 25
Prevail Therapeutics Enters into Licensing Agreement with RegenxBio 26
AveXis Enters into Licensing Agreement with Regenxbio 27
RegenxBio Exercises its Option Agreement with Voyager Therapeutics 29
Biogen Enters into Licensing Agreement with RegenxBio 30
Audentes Therapeutics Enters Into Licensing Agreement With RegenxBio 31
Audentes Therapeutics Enters into Licensing Agreement with RegenxBio for CPVT 32
ReGenX Biosciences Enters into Option And Licensing Agreement with Dimension Therapeutics 34
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 35
Voyager Therapeutics Enters into Licensing Agreement with ReGenX Biosciences 36
ReGenx Enters Into Licensing Agreement With AAVLife 38
AveXis Amends Licensing Agreement With ReGenX Biosciences 39
ReGenX Biosciences Enters Into Licensing Agreement With Lysogene 40
ReGenX Biosciences Amends Licensing Agreement With Dimension Therapeutics 41
Audentes Therapeutics Enters Into Licensing Agreement with ReGenX Biosciences 42
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 43
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 44
Equity Offering 45
RegenxBio Raises USD201.8 Million in Public Offering of Shares 45
RegenxBio Prices Public Offering of Shares for USD75.9 Million 47
RegenxBio Raises USD159.4 Million in IPO 49
Acquisition 51
RegenxBio to Acquire Dimension Therapeutics 51
RegenxBio Inc – Key Competitors 53
RegenxBio Inc – Key Employees 54
RegenxBio Inc – Locations And Subsidiaries 55
Head Office 55
Other Locations & Subsidiaries 55
Recent Developments 56
Strategy And Business Planning 56
May 15, 2018: REGENXBIO Joins the Mucopolysaccharidosis Community to Advance Research and Innovation 56
Aug 09, 2017: The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics 57
Financial Announcements 58
Nov 07, 2018: REGENXBIO reports third quarter 2018 financial and operating results and announces initiation of Phase I/II Clinical Trial for RGX-121 for the Treatment of MPS II 58
May 08, 2018: REGENXBIO Reports First Quarter 2018 Financial Results and Recent Operational Highlights 61
Mar 06, 2018: REGENXBIO Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights 63
Nov 08, 2017: REGENXBIO Reports Third Quarter 2017 Financial Results and Recent Operational Highlights 65
Aug 08, 2017: REGENXBIO Reports Second Quarter 2017 Financial Results and Recent Operational Highlights 67
May 09, 2017: REGENXBIO Reports First Quarter 2017 Financial Results and Recent Operational Highlights 69
Mar 07, 2017: REGENXBIO Reports Fourth Quarter and Full-Year 2016 Financial Results and Recent Operational Highlights 71
Jan 06, 2017: REGENXBIO Provides Year-End 2016 Corporate Update 73
Corporate Communications 75
May 29, 2018: REGENXBIO Names Alexandra Glucksmann As Board Director 75
Mar 28, 2017: REGENXBIO Enhances and Expands Scientific Leadership 76
Product News 77
Oct 26, 2018: REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2018 Annual Meeting 77
Clinical Trials 81
Feb 08, 2018: REGENXBIO Announces Completion of Dosing of Third Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD 81
Sep 20, 2017: REGENXBIO Announces Completion of Dosing of First Cohort in Phase I Clinical Trial of RGX-314 Gene Therapy for Wet AMD 82
Aug 11, 2017: REGENXBIO to Present on RGX-314 Gene Therapy Program for Wet AMD at 35th Annual Scientific Meeting of the American Society of Retina Specialists 83
Other Significant Developments 84
Oct 26, 2018: REGENXBIO Announces Additional Positive Interim Phase I Trial Update for RGX-314 for the Treatment of Wet AMD at the American Academy of Ophthalmology 2018 Annual Meeting 84
Jan 04, 2018: REGENXBIO Provides Year-End 2017 Corporate Update 88
Appendix 91
Methodology 91
About GlobalData 91
Contact Us 91
Disclaimer 91
RegenxBio Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
RegenxBio Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
RegenxBio Inc, Deals By Therapy Area, 2012 to YTD 2018 9
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
REGENXBIO Raises USD70.5 Million in Series D Financing 13
REGENXBIO Raises USD30 Million in Series C Financing 16
REGENXBIO Raises USD7.9 Million in Venture Financing 18
ReGenX Biosciences Raises US$7.9 Million In Venture Financing 19
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 20
Silverstein Foundation, RegenxBio and OrbiMed Advisors Form Joint Venture 21
ABL Enters into Contract Manufacturing Agreement with RegenxBio 22
Fidelity Biosciences Forms Joint Venture With ReGenX Biosciences 23
Abeona Therapeutics Enters into Licensing Agreement with RegenxBio 24
Ultragenyx Pharma Exercises Option for Licensing Agreement with Regenxbio 25
Prevail Therapeutics Enters into Licensing Agreement with RegenxBio 26
AveXis Enters into Licensing Agreement with Regenxbio 27
RegenxBio Exercises its Option Agreement with Voyager Therapeutics 29
Biogen Enters into Licensing Agreement with RegenxBio 30
Audentes Therapeutics Enters Into Licensing Agreement With RegenxBio 31
Audentes Therapeutics Enters into Licensing Agreement with RegenxBio for CPVT 32
ReGenX Biosciences Enters into Option And Licensing Agreement with Dimension Therapeutics 34
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 35
Voyager Therapeutics Enters into Licensing Agreement with ReGenX Biosciences 36
ReGenx Enters Into Licensing Agreement With AAVLife 38
AveXis Amends Licensing Agreement With ReGenX Biosciences 39
ReGenX Biosciences Enters Into Licensing Agreement With Lysogene 40
ReGenX Biosciences Amends Licensing Agreement With Dimension Therapeutics 41
Audentes Therapeutics Enters Into Licensing Agreement with ReGenX Biosciences 42
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A 43
ReGenX Biosciences Enters Into Licensing Agreement With Esteve 44
RegenxBio Raises USD201.8 Million in Public Offering of Shares 45
RegenxBio Prices Public Offering of Shares for USD75.9 Million 47
RegenxBio Raises USD159.4 Million in IPO 49
RegenxBio to Acquire Dimension Therapeutics 51
RegenxBio Inc, Key Competitors 53
RegenxBio Inc, Key Employees 54
RegenxBio Inc, Subsidiaries 55
List of Figures
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
RegenxBio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9